Literature DB >> 12954103

Production and characterization of monoclonal antibodies against hepatitis B viruses and application of a quick sandwich ELISA.

Fatima Yücel1, Aliihsan Manav, Aynur Başalp.   

Abstract

Hepatitis B virus (HBV) infection is a major health problem worldwide. The diagnosis of acute and chronic hepatitis B infection is based on the detection of hepatitis B surface antigen (HBsAg). We report here the development of hybrid cell producing monoclonal antibodies (MAbs) specific for HBsAg using hybridoma technology. BALB/c mice were immunized with a mixture of HBsAg subtype "ad" and subtype "ay." Spleen and lymph nodes were used as a source of high-titer antibody producing lymphocytes and removed and fused with myeloma cells of F0 origin separately. In the five fusion experiment, enzyme-linked immunosorbent assay (ELISA) tests showed that among 1594 hybridomas only 5 hybrids (9D12, 2B7, 4G5, 2G3, and 6E7) reacted with HBsAg. These MAbs were characterized for use in the development of diagnostic kits based on sandwich ELISA test system. The MAbs were conjugated with horseradish peroxidase (HRP) and used in the quick sandwich ELISA system. This system is a quite practical and time-saving test system when compared with common and commercial sandwich ELISA for diagnosis of hepatitis B surface antigen in human serum.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954103     DOI: 10.1089/153685903322286593

Source DB:  PubMed          Journal:  Hybrid Hybridomics        ISSN: 1536-8599


  2 in total

1.  Large scale generation and characterization of anti-human IgA monoclonal antibody in ascitic fluid of BALB/c mice.

Authors:  Fatemeh Ezzatifar; Jafar Majidi; Behzad Baradaran; Leili Aghebati Maleki; Jalal Abdolalizadeh; Mehdi Yousefi
Journal:  Adv Pharm Bull       Date:  2015-03-05

2.  A unique report: development of super anti-human IgG monoclone with optical density over than 3.

Authors:  Leili Aghebati Maleki; Behzad Baradaran; Jalal Abdolalizadeh; Fatemeh Ezzatifar; Jafar Majidi
Journal:  Adv Pharm Bull       Date:  2013-08-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.